Handelen Novo Nisk Adr Repsg 1 - NVO CFD
Toevoegen aan favorieten- Samenvatting
- Historische gegevens
- Evenementen
- Winst- en verliesrekening
- Balans
- Cash Flow
- Eigendom
Handelsvoorwaarden
| Spread | 0.48 | ||||||||
|
Overnight-tarief longpositie
Long position overnight fee
Ga naar platform | -0.030779% | ||||||||
|
Overnight-tarief shortpositie
Short position overnight fee
Ga naar platform | -0.013666% | ||||||||
| Tijd van overnight-tarief | 22:00 (UTC) | ||||||||
| Min. verhandelde hoeveelheid | 1 | ||||||||
| Valuta | USD | ||||||||
| Marge | 20% | ||||||||
| Effectenbeurs | United States of America | ||||||||
| Handelscommissie | 0% |
*Information provided by Capital.com
Novo Nordisk A/S ESG Risk Ratings
High Medium Low Negligible
‘A’ score indicates excellent relative ESG performance and high degree of transparency in reporting material ESG data publicly
Belangrijkste statistieken
| Prev. Close* | 137.65 |
| Open* | 138.29 |
| 1-Jaarlijkse Verandering* | 38.07% |
| Dagelijks bereik* | 137.97 - 139.31 |
| 52 wekelijks bereik | 94.75-144.78 |
| Weekgemiddelde volume (10 dagen) | 1.87M |
| Gemiddeld volume (3 maanden) | 29.48M |
| Marktkapitalisatie | 242.13B |
| P/E Ratio | 39.39 |
| Uitstaande Aandelen | 2.28B |
| Omzet | 25.50B |
| EPS | 3.51 |
| Dividend (opbrengst %) | 1.27941 |
| Beta | 0.48 |
| Volgende inkomsten datum | May 4, 2023 |
Alle gegevens zijn afkomstig van Refinitiv, behalve de gegevens gemarkeerd met een sterretje, die zijn afkomstig van Capital.com
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
| Date | Slotkoers | Change | Change (%) | Openingskoers | High | Low |
|---|---|---|---|---|---|---|
| Feb 7, 2023 | 139.17 | 0.89 | 0.64% | 138.28 | 139.67 | 136.87 |
| Feb 6, 2023 | 137.65 | 0.15 | 0.11% | 137.50 | 138.76 | 136.55 |
| Feb 3, 2023 | 136.30 | 0.66 | 0.49% | 135.64 | 137.38 | 134.50 |
| Feb 2, 2023 | 132.29 | -2.45 | -1.82% | 134.74 | 134.95 | 130.96 |
| Feb 1, 2023 | 138.68 | -0.99 | -0.71% | 139.67 | 140.07 | 135.90 |
| Jan 31, 2023 | 138.69 | 1.03 | 0.75% | 137.66 | 138.84 | 135.83 |
| Jan 30, 2023 | 138.79 | -1.84 | -1.31% | 140.63 | 140.66 | 138.53 |
| Jan 27, 2023 | 138.02 | 0.24 | 0.17% | 137.78 | 138.72 | 137.22 |
| Jan 26, 2023 | 137.10 | -1.34 | -0.97% | 138.44 | 138.76 | 135.96 |
| Jan 25, 2023 | 138.84 | 1.78 | 1.30% | 137.06 | 139.45 | 136.73 |
| Jan 24, 2023 | 139.55 | -1.91 | -1.35% | 141.46 | 141.46 | 138.42 |
| Jan 23, 2023 | 140.62 | -0.59 | -0.42% | 141.21 | 141.44 | 139.82 |
| Jan 20, 2023 | 140.71 | 0.48 | 0.34% | 140.23 | 141.05 | 138.81 |
| Jan 19, 2023 | 140.57 | 0.70 | 0.50% | 139.87 | 140.78 | 138.46 |
| Jan 18, 2023 | 139.39 | -0.31 | -0.22% | 139.70 | 140.85 | 138.96 |
| Jan 17, 2023 | 138.61 | -0.54 | -0.39% | 139.15 | 139.91 | 137.88 |
| Jan 13, 2023 | 135.93 | 0.40 | 0.30% | 135.53 | 136.77 | 135.03 |
| Jan 12, 2023 | 133.29 | 2.03 | 1.55% | 131.26 | 133.61 | 129.73 |
| Jan 11, 2023 | 132.23 | 1.41 | 1.08% | 130.82 | 132.56 | 130.12 |
| Jan 10, 2023 | 133.22 | -0.62 | -0.46% | 133.84 | 134.86 | 132.79 |
Novo Nisk Adr Repsg 1 Events
| Time (UTC) | Country | Event |
|---|---|---|
| No events scheduled | ||
- Jaarlijks
- Per kwartaal
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | |
|---|---|---|---|---|---|---|
| Totale inkomsten | 111780 | 111696 | 111831 | 122021 | 126946 | 140800 |
| Inkomsten | 111780 | 111696 | 111831 | 122021 | 126946 | 140800 |
| Kosten van opbrengsten, totaal | 17183 | 17632 | 17617 | 19559 | 20932 | 23658 |
| Brutowinst | 94597 | 94064 | 94214 | 102462 | 106014 | 117142 |
| Totale bedrijfskosten | 63348 | 62729 | 64583 | 69538 | 72820 | 82156 |
| Verkoop/Algemeen/Admin. Uitgaven, Totaal | 32630 | 32384 | 33656 | 35301 | 36108 | 40409 |
| Onderzoek & Ontwikkeling | 13643 | 13278 | 13568 | 13477 | 13713 | 16292 |
| Depreciation / Amortization | 513 | 586 | 1289 | 856 | 2178 | 1631 |
| Ongebruikelijke uitgaven (inkomsten) | 542 | 312 | -6 | 1200 | 477 | 714 |
| Other Operating Expenses, Total | -1163 | -1463 | -1541 | -855 | -588 | -548 |
| Bedrijfsresultaat | 48432 | 48967 | 47248 | 52483 | 54126 | 58644 |
| Renteopbrengsten (-uitgaven), netto Niet-operationeel | -549 | -219 | 439 | -3757 | -846 | 558 |
| Overige, Netto | -85 | -68 | -72 | -173 | -150 | -122 |
| Netto inkomen voor belastingen | 47798 | 48680 | 47615 | 48553 | 53130 | 59080 |
| Netto inkomen na belastingen | 37925 | 38130 | 38628 | 38951 | 42138 | 47757 |
| Netto inkomen voor extra. Posten | 37925 | 38130 | 38628 | 38951 | 42138 | 47757 |
| Netto inkomen | 37925 | 38130 | 38628 | 38951 | 42138 | 47757 |
| Inkomsten beschikbaar voor gewone aandelen Excl. Extra. Posten | 37925 | 38130 | 38628 | 38951 | 42138 | 47757 |
| Inkomsten beschikbaar voor gewone aandelen Incl. Extra. Posten | 37925 | 38130 | 38628 | 38951 | 42138 | 47757 |
| Verwateringsaanpassing | 0 | 0 | ||||
| Verwaterd Netto Inkomen | 37925 | 38130 | 38628 | 38951 | 42138 | 47757 |
| Verwaterd Gewogen Gemiddelde Aandelen | 2534.73 | 2478.09 | 2424.42 | 2378.66 | 2340 | 2303.1 |
| Verwaterde Winst per Aandeel Exclusief Buitengewone Posten | 14.9621 | 15.3868 | 15.9329 | 16.3752 | 18.0077 | 20.736 |
| Dividends per Share - Common Stock Primary Issue | 9.97126 | 7.09867 | 8.25759 | 8.14263 | 7.92244 | 9.6303 |
| Verwaterde Genormaliseerde Winst per Aandeel | 15.1318 | 15.4854 | 15.9309 | 16.7799 | 18.1694 | 20.9866 |
| Q1 2021 | Q2 2021 | Q3 2021 | Q4 2021 | Q1 2022 | |
|---|---|---|---|---|---|
| Totale inkomsten | 33804 | 33041 | 35622 | 38333 | 42031 |
| Inkomsten | 33804 | 33041 | 35622 | 38333 | 42031 |
| Kosten van opbrengsten, totaal | 5811 | 5547 | 6059 | 6241 | 6917 |
| Brutowinst | 27993 | 27494 | 29563 | 32092 | 35114 |
| Totale bedrijfskosten | 18822 | 18262 | 20373 | 24699 | 22884 |
| Verkoop/Algemeen/Admin. Uitgaven, Totaal | 9188 | 8905 | 10143 | 12822 | 11153 |
| Onderzoek & Ontwikkeling | 3944 | 3944 | 4252 | 5632 | 5206 |
| Other Operating Expenses, Total | -121 | -134 | -81 | 4 | -392 |
| Bedrijfsresultaat | 14982 | 14779 | 15249 | 13634 | 19147 |
| Renteopbrengsten (-uitgaven), netto Niet-operationeel | 956 | 138 | -137 | -521 | -1228 |
| Netto inkomen voor belastingen | 15938 | 14917 | 15112 | 13113 | 17919 |
| Netto inkomen na belastingen | 12623 | 12123 | 12119 | 10892 | 14210 |
| Netto inkomen voor extra. Posten | 12623 | 12123 | 12119 | 10892 | 14210 |
| Netto inkomen | 12623 | 12123 | 12119 | 10892 | 14210 |
| Inkomsten beschikbaar voor gewone aandelen Excl. Extra. Posten | 12623 | 12123 | 12119 | 10892 | 14210 |
| Inkomsten beschikbaar voor gewone aandelen Incl. Extra. Posten | 12623 | 12123 | 12119 | 10892 | 14210 |
| Verwaterd Netto Inkomen | 12623 | 12123 | 12119 | 10892 | 14210 |
| Verwaterd Gewogen Gemiddelde Aandelen | 2315.6 | 2306.3 | 2297.3 | 2320.5 | 2283.3 |
| Verwaterde Winst per Aandeel Exclusief Buitengewone Posten | 5.45129 | 5.25647 | 5.27532 | 4.69382 | 6.22345 |
| Dividends per Share - Common Stock Primary Issue | 0 | 5.78289 | 0 | 3.59917 | 0 |
| Verwaterde Genormaliseerde Winst per Aandeel | 5.45129 | 5.25647 | 5.27532 | 4.69382 | 6.22345 |
- Jaarlijks
- Per kwartaal
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | |
|---|---|---|---|---|---|---|
| Totaal vlottende activa | 59766 | 60080 | 59067 | 62456 | 65809 | 85595 |
| Geldmiddelen en kortetermijnbeleggingen | 20699 | 18852 | 15638 | 14966 | 12104 | 16362 |
| Cash | 18690 | 18852 | 15638 | 14966 | 12104 | 9597 |
| Korte Termijn Investeringen | 2009 | 0 | 6765 | |||
| Totale Vorderingen, Netto | 22613 | 21938 | 24836 | 29152 | 32184 | 46799 |
| Accounts Receivable - Trade, Net | 20234 | 20165 | 22786 | 24912 | 27734 | 40643 |
| Total Inventory | 14341 | 15373 | 16336 | 17641 | 18536 | 19621 |
| Prepaid Expenses | 1584 | 1613 | 2053 | |||
| Other Current Assets, Total | 529 | 2304 | 204 | 697 | 2985 | 2813 |
| Total Assets | 97539 | 102355 | 110769 | 125612 | 144922 | 194508 |
| Property/Plant/Equipment, Total - Net | 30179 | 35247 | 41891 | 50551 | 50269 | 55362 |
| Property/Plant/Equipment, Total - Gross | 58024 | 64661 | 72438 | 84420 | 86686 | 95887 |
| Accumulated Depreciation, Total | -27845 | -29414 | -30547 | -33869 | -36417 | -40525 |
| Intangibles, Net | 2714 | 3325 | 5145 | 5835 | 20657 | 38825 |
| Long Term Investments | 1508 | 1195 | 1296 | 1444 | 1348 | 1078 |
| Note Receivable - Long Term | 689 | 567 | 477 | 1205 | 974 | 630 |
| Other Long Term Assets, Total | 2683 | 1941 | 2893 | 4121 | 5865 | 8672 |
| Total Current Liabilities | 47436 | 47056 | 54164 | 58983 | 70273 | 99516 |
| Accounts Payable | 6011 | 5610 | 6756 | 6358 | 5717 | 8870 |
| Accrued Expenses | 11051 | 6799 | 7015 | 478 | 598 | 590 |
| Notes Payable/Short Term Debt | 229 | 1694 | 515 | 659 | 6684 | 12862 |
| Other Current Liabilities, Total | 30145 | 32953 | 39878 | 50673 | 56499 | 76372 |
| Total Liabilities | 52270 | 52540 | 58930 | 68019 | 81597 | 123762 |
| Total Long Term Debt | 0 | 0 | 0 | 3009 | 2897 | 12961 |
| Deferred Income Tax | 13 | 846 | 118 | 80 | 2502 | 5271 |
| Other Liabilities, Total | 4821 | 4638 | 4648 | 5947 | 5925 | 6014 |
| Total Equity | 45269 | 49815 | 51839 | 57593 | 63325 | 70746 |
| Common Stock | 510 | 500 | 490 | 480 | 470 | 462 |
| Retained Earnings (Accumulated Deficit) | 47607 | 48855 | 54102 | 58291 | 63589 | 72934 |
| Treasury Stock - Common | -9 | -11 | -11 | -10 | -8 | -6 |
| Other Equity, Total | -2839 | 471 | -2742 | -1168 | -726 | -2644 |
| Total Liabilities & Shareholders’ Equity | 97539 | 102355 | 110769 | 125612 | 144922 | 194508 |
| Total Common Shares Outstanding | 537.436 | 2444 | 2394 | 2352 | 2312.5 | 2276.04 |
| Current Port. of LT Debt/Capital Leases | 815 | 775 | 822 | |||
| Capital Lease Obligations | 3009 | 2897 | 3307 | |||
| Goodwill, Net | 4346 | |||||
| Long Term Debt | 9654 |
| Mar 2021 | Jun 2021 | Sep 2021 | Dec 2021 | Mar 2022 | |
|---|---|---|---|---|---|
| Totaal vlottende activa | 61389 | 77146 | 91213 | 85595 | 86537 |
| Geldmiddelen en kortetermijnbeleggingen | 7666 | 27216 | 35390 | 17485 | 20146 |
| Cash | 5683 | 24229 | 29493 | 10720 | 13394 |
| Korte Termijn Investeringen | 1983 | 2987 | 5897 | 6765 | 6752 |
| Totale Vorderingen, Netto | 33917 | 30223 | 35452 | 46799 | 44166 |
| Accounts Receivable - Trade, Net | 28029 | 26098 | 29860 | 40643 | 36241 |
| Total Inventory | 18653 | 18822 | 18899 | 19621 | 20289 |
| Other Current Assets, Total | 1153 | 885 | 1472 | 1690 | 1936 |
| Total Assets | 141387 | 158095 | 174084 | 194508 | 197136 |
| Property/Plant/Equipment, Total - Net | 51429 | 52076 | 52863 | 55362 | 56399 |
| Intangibles, Net | 20357 | 20272 | 20526 | 43171 | 43344 |
| Long Term Investments | 1749 | 1839 | 1778 | 1441 | 1279 |
| Note Receivable - Long Term | 551 | 413 | 332 | 267 | 239 |
| Other Long Term Assets, Total | 5912 | 6349 | 7372 | 8672 | 9338 |
| Total Current Liabilities | 72384 | 72798 | 88328 | 99516 | 95602 |
| Accounts Payable | 6800 | 7616 | 8877 | 8870 | 6679 |
| Notes Payable/Short Term Debt | 0 | 0 | 0 | 0 | 0 |
| Current Port. of LT Debt/Capital Leases | 6823 | 1301 | 1350 | 13684 | 1396 |
| Other Current Liabilities, Total | 58761 | 63881 | 78101 | 76962 | 87527 |
| Total Liabilities | 82891 | 92536 | 107972 | 123762 | 130586 |
| Total Long Term Debt | 2832 | 12463 | 12398 | 12961 | 24084 |
| Long Term Debt | 2832 | 12463 | 12398 | 12961 | 24084 |
| Deferred Income Tax | 1963 | 1818 | 1643 | 5271 | 5305 |
| Other Liabilities, Total | 5712 | 5457 | 5603 | 6014 | 5595 |
| Total Equity | 58496 | 65559 | 66112 | 70746 | 66550 |
| Common Stock | 470 | 462 | 462 | 462 | 462 |
| Retained Earnings (Accumulated Deficit) | 58035 | 65100 | 65654 | 70290 | 66095 |
| Treasury Stock - Common | -9 | -3 | -4 | -6 | -7 |
| Total Liabilities & Shareholders’ Equity | 141387 | 158095 | 174084 | 194508 | 197136 |
| Total Common Shares Outstanding | 2272.06 | 2272.06 | 2272.06 | 2276.04 | 2276.04 |
- Jaarlijks
- Per kwartaal
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | |
|---|---|---|---|---|---|---|
| Netto-inkomen/Beginsaldo | 37925 | 38130 | 38628 | 38951 | 42138 | 47757 |
| Geldmiddelen uit Operationele Activiteiten | 48314 | 41168 | 45028 | 46782 | 51951 | 55000 |
| Geldmiddelen uit Operationele Activiteiten | 3193 | 3182 | 3925 | 5661 | 5753 | 6025 |
| Niet-Geldelijke Posten | 13755 | 12577 | 15085 | 16634 | 18841 | 24332 |
| Cash Taxes Paid | 2899 | 9101 | 9614 | 10936 | 10106 | 14438 |
| Contant Betaalde Rente | 66 | 87 | 89 | 204 | 422 | 261 |
| Veranderingen in het Operationeel Kapitaal | -6559 | -12721 | -12610 | -14464 | -14781 | -23114 |
| Geldmiddelen uit Investeringsactiviteiten | -6790 | -6571 | -12080 | -11509 | -22436 | -31605 |
| Kapitaaluitgaven | -8267 | -8648 | -12410 | -11231 | -22081 | -7385 |
| Overige Cash Flow investeringsposten, Totaal | 1477 | 2077 | 330 | -278 | -355 | -24220 |
| Geldmiddelen uit Financieringsactiviteiten | -38887 | -35689 | -34521 | -35484 | -32244 | -25493 |
| Total Cash Dividends Paid | -23830 | -18844 | -19048 | -19409 | -20121 | -21517 |
| Uitgifte (Aflossing) van aandelen, netto | -15057 | -16845 | -15567 | -15334 | -16855 | -19447 |
| Wisselkoerseffecten | -26 | -211 | 44 | -7 | -456 | 591 |
| Nettowijziging in Geldmiddelen | 2611 | -1303 | -1529 | -218 | -3185 | -1507 |
| Uitgifte (Aflossing) van Schulden, Netto | 94 | -741 | 4732 | 15471 |
| Mar 2021 | Jun 2021 | Sep 2021 | Dec 2021 | Mar 2022 | |
|---|---|---|---|---|---|
| Net income/Starting Line | 12623 | 24746 | 36865 | 47757 | 14210 |
| Cash From Operating Activities | 11255 | 36510 | 58017 | 55000 | 23586 |
| Cash From Operating Activities | 1377 | 2594 | 3943 | 6025 | 1650 |
| Non-Cash Items | 4349 | 15281 | 23749 | 24332 | 11097 |
| Cash Taxes Paid | 5931 | 7808 | 8580 | 14438 | 5260 |
| Cash Interest Paid | 50 | 85 | 141 | 261 | 52 |
| Changes in Working Capital | -7094 | -6111 | -6540 | -23114 | -3371 |
| Cash From Investing Activities | -3481 | -6367 | -11002 | -31605 | -1907 |
| Capital Expenditures | -1499 | -3383 | -5071 | -7385 | -1780 |
| Other Investing Cash Flow Items, Total | -1982 | -2984 | -5931 | -24220 | -127 |
| Cash From Financing Activities | -14475 | -18311 | -30042 | -25493 | -19135 |
| Financing Cash Flow Items | 2329 | 2737 | |||
| Total Cash Dividends Paid | -13495 | -13496 | -21517 | -21517 | -15690 |
| Issuance (Retirement) of Stock, Net | -2960 | -8400 | -11935 | -19447 | -4477 |
| Issuance (Retirement) of Debt, Net | -349 | 3585 | 3410 | 15471 | -1705 |
| Foreign Exchange Effects | 154 | 169 | 291 | 591 | -55 |
| Net Change in Cash | -6547 | 12001 | 17264 | -1507 | 2489 |
| Naam investeerder | Type investeerder | Percentage uitstaand | Aandelen in bezit | Wijziging aandelen | Datum bezit | Omzetcijfer |
|---|---|---|---|---|---|---|
| Renaissance Technologies LLC | Hedge Fund | 0.8783 | 15308871 | -2220800 | 2022-09-30 | HIGH |
| Jennison Associates LLC | Investment Advisor/Hedge Fund | 0.6271 | 10930506 | 413285 | 2022-09-30 | LOW |
| Fisher Investments | Investment Advisor/Hedge Fund | 0.5178 | 9026001 | -306861 | 2022-12-31 | LOW |
| Capital International Investors | Investment Advisor | 0.3603 | 6279859 | 58068 | 2022-09-30 | LOW |
| Fayez Sarofim & Co. | Investment Advisor | 0.2994 | 5218104 | 450280 | 2022-09-30 | LOW |
| Loomis, Sayles & Company, L.P. | Investment Advisor/Hedge Fund | 0.297 | 5177389 | -138349 | 2022-09-30 | LOW |
| Managed Account Advisors LLC | Investment Advisor | 0.2562 | 4465925 | 184833 | 2022-09-30 | LOW |
| Folketrygdfondet | Pension Fund | 0.2446 | 4262659 | 119781 | 2022-09-30 | LOW |
| WCM Investment Management | Investment Advisor | 0.2161 | 3766983 | -83070 | 2022-09-30 | LOW |
| State Street Global Advisors (US) | Investment Advisor/Hedge Fund | 0.2025 | 3528815 | -27044 | 2022-09-30 | LOW |
| State Farm Insurance Companies | Insurance Company | 0.1996 | 3479090 | 0 | 2022-09-30 | LOW |
| Everett Harris & Co. | Investment Advisor | 0.1904 | 3319309 | 3219 | 2022-12-31 | LOW |
| BofA Global Research (US) | Research Firm | 0.1638 | 2855711 | -16615 | 2022-09-30 | LOW |
| Parametric Portfolio Associates LLC | Investment Advisor | 0.1521 | 2651790 | 56485 | 2022-09-30 | LOW |
| Envestnet Asset Management, Inc. | Investment Advisor | 0.1035 | 1804466 | -3165 | 2022-09-30 | LOW |
| Northern Trust Global Investments | Investment Advisor | 0.1016 | 1771364 | -24950 | 2022-09-30 | LOW |
| Aperio Group, LLC | Investment Advisor | 0.0938 | 1635017 | -39785 | 2022-09-30 | LOW |
| Wells Fargo Advisors | Research Firm | 0.0902 | 1573006 | -182638 | 2022-09-30 | LOW |
| Goldman Sachs Asset Management, L.P. | Investment Advisor | 0.0855 | 1490734 | 12584 | 2022-09-30 | LOW |
| BlackRock Investment Management, LLC | Investment Advisor/Hedge Fund | 0.0854 | 1488034 | -41020 | 2022-09-30 | LOW |
Waarom Capital.com? De cijfers spreken voor zichzelf.
Capital.com Group +500000+
Handelaren
93000+
Actieve klanten per maand
$57000000+
Maandelijks beleggingsvolume
$31000000+
Probeer het nu Opgenomen per maand
Handelscalculator
Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).
Handelscommissie
0
- 1:1
- 2:1
- 5:1
- 10:1
- 20:1
Hefboom
20:1
- 20
- 100
- 500
- 1000
- 10000
Investering
Positiegrootte (hefboomwerking x investering):
Openingskoers
Slotkoers
Short Long
Nordisk ADR Company profile
Over Novo Nisk Adr Repsg 1
Novo Nordisk A/S is een wereldwijd actief gezondheidszorgbedrijf dat zich bezighoudt met diabeteszorg. De onderneming houdt zich ook bezig met de ontdekking, ontwikkeling, productie en marketing van farmaceutische producten. De onderneming is actief in twee bedrijfssegmenten: diabetes- en obesitaszorg en biofarmaceutische producten. Het segment diabetes- en obesitaszorg van de Vennootschap omvat insuline, GLP-1, andere eiwitgerelateerde producten, zoals glucagon, eiwitgerelateerde toedieningssystemen en naalden, en orale anti-diabetesmedicijnen. Het biofarmaceutische segment van de Vennootschap omvat de therapeutische gebieden van hemofiliezorg, groeihormoontherapie en hormoonvervangingstherapie. De Onderneming biedt ook het product Saxenda aan voor de behandeling van zwaarlijvigheid. Het biedt een reeks producten aan, waaronder NovoLog/NovoRapid; NovoLog Mix/NovoMix; Prandin/NovoNorm; NovoSeven; Norditropin, en Vagifem. Per 31 december 2016 bracht het zijn producten in meer dan 180 landen op de markt. Haar regionale structuur bestaat uit twee commerciële eenheden: Noord-Amerika en Internationale Operaties.
| Industry: | Pharmaceuticals (NEC) |
Novo Alle 1
BAGSVAERD
2880
DK
Winst- en verliesrekening
- Annual
- Quarterly
Mensen bekijken ook
Nog steeds op zoek naar een broker die u kunt vertrouwen?
Sluit u aan bij de 500.000+ handelaren die er wereldwijd voor kozen om met Capital.com te handelen